Kumovis is a German startup that offers innovative medical manufacturing solutions utilizing 3D printing, clean room technology, and regulatory support for patient-matched implants. Since its establishment in 2017 in Munich, the company has been at the forefront of revolutionizing the healthcare industry by focusing on enhancing patient care through its unique approach to manufacturing.
Unlike traditional 3D printer manufacturers, Kumovis has dedicated itself to developing end-to-end workflows tailored specifically for medical applications. Their approach involves integrating clean room technology with a proprietary 3D printing solution, prioritizing the cost-effective production of high-performance polymer-based implants and instruments. These products are optimized to meet individual patient needs, reflecting the company's commitment to personalized healthcare solutions.
In addition to its manufacturing capabilities, Kumovis provides essential support to medical device companies and hospitals by offering a regulatory roadmap and documentation. This streamlined process for next-generation medical technology is designed to better serve patients and improve overall healthcare outcomes.
The company received a significant boost with a €5.40M Series A investment on 01 June 2020, with funding from notable investors including High-Tech Gründerfonds, Syensqo Ventures, and American RENOLIT Corporation. This investment reflects a strong endorsement of Kumovis's vision and capabilities within the healthcare and manufacturing industries.
Overall, Kumovis exemplifies the potential for disruptive innovation in the medical manufacturing sector, combining advanced technology, regulatory expertise, and a patient-centric approach to drive positive change in healthcare delivery.
No recent news or press coverage available for Kumovis.